Discovery of Unique Molecular Pathways in Patients with Lupus Nephritis for the Development of Novel Precision Therapies
Virginia Pascual, Gale and Ira Drukier Director of Children's Health Research, Ronay Menschel Professor of Pediatrics
Development of a Novel Antioxidant Gene Therapy for the Treatment of Ocular Disorders
Stephen Kaminsky, Professor of Research in Genetic Medicine
Novel Ex Vivo Organoid Model Platform for Drug Development in Cancer and Cardiovascular Disease
Olivier Elemento, Director of the Englander Institute for Precision Medicine
Novel Platform for Target Discovery and Validation for Chronic Lung Disease Using Personalized 3D Lung Tissue Units
Renat Shaykhiev, Associate Professor of Medicine
Key Enabling Technology for the Development of Novel Therapeutics for Age-Related Macular Degeneration
Ching-Hwa Sung, The Betty Neuwirth Lee and Chilly Professor in Stem Cell Research
Development of Novel Therapeutics for Chronic Inflammation by Leveraging Innate Lymphocyte Populations
Gregory Sonnenberg, The Henry R. Erle, M.D.-Roberts Family Associate Professor of Medicine
Developing Novel First-in-Class Therapeutics for Colorectal Cancer
Gregory Sonnenberg, The Henry R. Erle, M.D.-Roberts Family Associate Professor of Medicine
Development of A Novel Multi-functional Compound for the Treatment of Autoimmune Disorders
Laura Santambrogio, Professor of Radiation Oncology
Discovery Platform for Deep Target Mining of Tractable Targets for the Development of First-in-Class Therapeutics for Neuroendocrine Prostate Cancer
David S. Rickman, Associate Professor of Pathology and Laboratory Medicine
Innovative Personalized Medicine Platform that Recapitulates the Human Immune System for the Development of Novel Oncology Therapeutics
Giorgio Inghirami, Professor of Pathology and Laboratory Medicine